查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1872154

远距精神病学：全球市场份额和排名、总收入和需求预测（2025-2031 年）

Telepsychiatry - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 114 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球远距精神病学市场规模估计为 7.13 亿美元，预计到 2031 年将达到 29.58 亿美元，在预测期（2025-2031 年）内以 22.1% 的复合年增长率增长。

远距精神医学是一种远端医疗形式，它透过视讯会议、语音通讯和数位平台远端提供精神科诊疗服务。其服务范围广泛，包括诊断评估、药物管理、个人和团体治疗、患者教育以及后续追踪。远距精神医学显着改善了精神卫生服务的可及性，尤其是在农村、偏远和医疗资源匮乏的地区，有助于弥合精神健康服务供需之间的差距。随着云端基础平台、人工智慧辅助诊断和电子健康记录（EHR）的整合，远距精神医学正成为推动精神卫生服务数位转型和扩展的关键力量。

随着忧郁症、焦虑症和青少年心理障碍在后疫情时代成为主要的公共卫生问题，全球对心理健康服务的需求持续增长。根据美国疾病管制与预防中心（CDC）、英国国家医疗服务体系（NHS）和中国国家卫生健康委员会的数据，远距精神医学已成为各国政府推广全民心理健康服务覆盖的核心工具。大型医疗机构（例如凯撒医疗集团和梅奥诊所）、科技平台（例如Teladoc Health和MDLive）以及社区健康系统正在增加对远距精神医学的投资。人工智慧驱动的预筛检、个人化治疗流程以及与电子健康记录（EHR）的深度整合正在推动该行业的快速发展。放宽的保险报销政策（例如美国医疗保险的扩展）和企业健康计划预算的增加进一步加速了市场渗透。

儘管远距精神医学发展迅速，但仍面临许多挑战，包括医病沟通不良、资料安全隐患以及医疗专业人员跨区域执业许可的复杂性。在许多开发中国家，数位基础设施不足、训练有素的专业人员短缺以及支付体係不完善限制了远距精神医学的普及。此外，该行业对政策高度敏感，更严格的报销规定或放鬆管制都可能导致市场波动。

企业员工健康计画、老年人心理健康服务、学校咨商平台和青少年行为疗法是成长最快的应用领域。保险公司、企业健康管理平台、教育机构和大型健康维护组织（HMO）正成为远距心理健康服务的主要购买者。展望未来，自适应人工智慧驱动的治疗系统、全天候虚拟精神科诊所和行动端心理健康应用程式（例如聊天机器人）有望塑造该行业的未来。

本报告旨在对全球远距精神病学市场进行全面分析，重点关注总收入、市场份额和主要企业的排名，并按地区/国家、类型和最终用户对远距精神病学进行分析。

本报告以销售收入为指标，根据2020年至2031年的历史资料和预测资料（以2024年为基准年），呈现远距精神科市场的规模、估计和预测。我们运用定量和定性分析相结合的方法，旨在帮助读者制定业务/成长策略，评估市场竞争格局，分析公司在当前市场中的地位，并就远距精神病学做出明智的商业决策。

市场区隔

公司

  • Teladoc Health
  • American Telepsychiatrists
  • American Well
  • Doxy.me
  • Advanced Telemed Services
  • Cerebral
  • Talkiatry
  • Talkspace
  • Arcadian Telepsychiatry
  • MDLIVE Behavioral Health
  • Thriveworks
  • Lyra Health
  • Psychiatric Alternatives
  • MyndYou
  • PlushCare

按类型分類的细分市场

  • 日常远距精神病学
  • 法医远距精神病学
  • 危机远距精神病学
  • 家庭远距精神科

最终使用者群体

  • 成人
  • 青少年
  • 老年人

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Telepsychiatry was estimated to be worth US$ 713 million in 2024 and is forecast to a readjusted size of US$ 2958 million by 2031 with a CAGR of 22.1% during the forecast period 2025-2031.

Telepsychiatry is a form of telemedicine that enables the remote delivery of psychiatric care through video conferencing, voice communication, and digital platforms. It encompasses a wide range of services including diagnostic assessments, medication management, individual and group therapy, as well as patient education and follow-up. Telepsychiatry significantly improves access to mental health services, particularly in rural, remote, or underserved areas, and helps to bridge the gap between demand and supply of psychiatric care. With the integration of cloud-based platforms, AI-assisted diagnostics, and electronic health records (EHRs), telepsychiatry is becoming a vital driver in the digital transformation and expansion of mental health services.

In the post-pandemic era, global demand for mental health services continues to rise, with depression, anxiety, and adolescent mental disorders becoming major public health concerns. According to data from the CDC, NHS, and China's National Health Commission, telepsychiatry is now a core tool for governments to promote widespread mental health coverage. Major healthcare providers (e.g., Kaiser Permanente, Mayo Clinic), tech platforms (e.g., Teladoc Health, MDLive), and regional health systems are expanding investments in telepsychiatry. AI-powered pre-screening, personalized therapy algorithms, and deeper integration with EHRs are fueling rapid industry growth. Relaxation of reimbursement policies (e.g., U.S. Medicare expansion) and increased budgets for corporate wellness programs further accelerate market penetration.

Despite rapid adoption, telepsychiatry faces notable challenges, including weaker doctor-patient connections, concerns over data security, and complex cross-regional licensing for practitioners. In many developing countries, insufficient digital infrastructure, lack of trained professionals, and underdeveloped payment systems limit adoption. Moreover, the industry is policy-sensitive-any tightening of reimbursement rules or regulatory rollback could trigger market volatility.

Enterprise employee wellness programs, elderly mental care services, school counseling platforms, and adolescent behavioral therapy are among the fastest-growing application areas. Insurance companies, employer health platforms, educational institutions, and major HMOs are becoming key purchasers of telepsychiatry services. Looking ahead, adaptive AI-driven therapy systems, 24/7 virtual psychiatric clinics, and mobile-based mental health apps (like chatbots) are expected to shape the future of the industry.

This report aims to provide a comprehensive presentation of the global market for Telepsychiatry, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Telepsychiatry by region & country, by Type, and by End User.

The Telepsychiatry market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Telepsychiatry.

Market Segmentation

By Company

  • Teladoc Health
  • American Telepsychiatrists
  • American Well
  • Doxy.me
  • Advanced Telemed Services
  • Cerebral
  • Talkiatry
  • Talkspace
  • Arcadian Telepsychiatry
  • MDLIVE Behavioral Health
  • Thriveworks
  • Lyra Health
  • Psychiatric Alternatives
  • MyndYou
  • PlushCare

Segment by Type

  • Routine Telepsychiatry
  • Forensic Telepsychiatry
  • Crisis Telepsychiatry
  • In-Home Telepsychiatry

Segment by End User

  • Adults
  • Teenagers
  • Geriatric Populations

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Telepsychiatry company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Telepsychiatry in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Telepsychiatry in country level. It provides sigmate data by Type, and by End User for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Telepsychiatry Product Introduction
  • 1.2 Global Telepsychiatry Market Size Forecast (2020-2031)
  • 1.3 Telepsychiatry Market Trends & Drivers
    • 1.3.1 Telepsychiatry Industry Trends
    • 1.3.2 Telepsychiatry Market Drivers & Opportunity
    • 1.3.3 Telepsychiatry Market Challenges
    • 1.3.4 Telepsychiatry Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Telepsychiatry Players Revenue Ranking (2024)
  • 2.2 Global Telepsychiatry Revenue by Company (2020-2025)
  • 2.3 Key Companies Telepsychiatry Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Telepsychiatry Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Telepsychiatry
  • 2.6 Telepsychiatry Market Competitive Analysis
    • 2.6.1 Telepsychiatry Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Telepsychiatry Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Telepsychiatry as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Routine Telepsychiatry
    • 3.1.2 Forensic Telepsychiatry
    • 3.1.3 Crisis Telepsychiatry
    • 3.1.4 In-Home Telepsychiatry
  • 3.2 Global Telepsychiatry Sales Value by Type
    • 3.2.1 Global Telepsychiatry Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Telepsychiatry Sales Value, by Type (2020-2031)
    • 3.2.3 Global Telepsychiatry Sales Value, by Type (%) (2020-2031)

4 Segmentation by End User

  • 4.1 Introduction by End User
    • 4.1.1 Adults
    • 4.1.2 Teenagers
    • 4.1.3 Geriatric Populations
  • 4.2 Global Telepsychiatry Sales Value by End User
    • 4.2.1 Global Telepsychiatry Sales Value by End User (2020 VS 2024 VS 2031)
    • 4.2.2 Global Telepsychiatry Sales Value, by End User (2020-2031)
    • 4.2.3 Global Telepsychiatry Sales Value, by End User (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Telepsychiatry Sales Value by Region
    • 5.1.1 Global Telepsychiatry Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Telepsychiatry Sales Value by Region (2020-2025)
    • 5.1.3 Global Telepsychiatry Sales Value by Region (2026-2031)
    • 5.1.4 Global Telepsychiatry Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Telepsychiatry Sales Value, 2020-2031
    • 5.2.2 North America Telepsychiatry Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Telepsychiatry Sales Value, 2020-2031
    • 5.3.2 Europe Telepsychiatry Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Telepsychiatry Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Telepsychiatry Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Telepsychiatry Sales Value, 2020-2031
    • 5.5.2 South America Telepsychiatry Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Telepsychiatry Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Telepsychiatry Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Telepsychiatry Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Telepsychiatry Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Telepsychiatry Sales Value, 2020-2031
    • 6.3.2 United States Telepsychiatry Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Telepsychiatry Sales Value by End User, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Telepsychiatry Sales Value, 2020-2031
    • 6.4.2 Europe Telepsychiatry Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Telepsychiatry Sales Value by End User, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Telepsychiatry Sales Value, 2020-2031
    • 6.5.2 China Telepsychiatry Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Telepsychiatry Sales Value by End User, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Telepsychiatry Sales Value, 2020-2031
    • 6.6.2 Japan Telepsychiatry Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Telepsychiatry Sales Value by End User, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Telepsychiatry Sales Value, 2020-2031
    • 6.7.2 South Korea Telepsychiatry Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Telepsychiatry Sales Value by End User, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Telepsychiatry Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Telepsychiatry Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Telepsychiatry Sales Value by End User, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Telepsychiatry Sales Value, 2020-2031
    • 6.9.2 India Telepsychiatry Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Telepsychiatry Sales Value by End User, 2024 VS 2031

7 Company Profiles

  • 7.1 Teladoc Health
    • 7.1.1 Teladoc Health Profile
    • 7.1.2 Teladoc Health Main Business
    • 7.1.3 Teladoc Health Telepsychiatry Products, Services and Solutions
    • 7.1.4 Teladoc Health Telepsychiatry Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Teladoc Health Recent Developments
  • 7.2 American Telepsychiatrists
    • 7.2.1 American Telepsychiatrists Profile
    • 7.2.2 American Telepsychiatrists Main Business
    • 7.2.3 American Telepsychiatrists Telepsychiatry Products, Services and Solutions
    • 7.2.4 American Telepsychiatrists Telepsychiatry Revenue (US$ Million) & (2020-2025)
    • 7.2.5 American Telepsychiatrists Recent Developments
  • 7.3 American Well
    • 7.3.1 American Well Profile
    • 7.3.2 American Well Main Business
    • 7.3.3 American Well Telepsychiatry Products, Services and Solutions
    • 7.3.4 American Well Telepsychiatry Revenue (US$ Million) & (2020-2025)
    • 7.3.5 American Well Recent Developments
  • 7.4 Doxy.me
    • 7.4.1 Doxy.me Profile
    • 7.4.2 Doxy.me Main Business
    • 7.4.3 Doxy.me Telepsychiatry Products, Services and Solutions
    • 7.4.4 Doxy.me Telepsychiatry Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Doxy.me Recent Developments
  • 7.5 Advanced Telemed Services
    • 7.5.1 Advanced Telemed Services Profile
    • 7.5.2 Advanced Telemed Services Main Business
    • 7.5.3 Advanced Telemed Services Telepsychiatry Products, Services and Solutions
    • 7.5.4 Advanced Telemed Services Telepsychiatry Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Advanced Telemed Services Recent Developments
  • 7.6 Cerebral
    • 7.6.1 Cerebral Profile
    • 7.6.2 Cerebral Main Business
    • 7.6.3 Cerebral Telepsychiatry Products, Services and Solutions
    • 7.6.4 Cerebral Telepsychiatry Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Cerebral Recent Developments
  • 7.7 Talkiatry
    • 7.7.1 Talkiatry Profile
    • 7.7.2 Talkiatry Main Business
    • 7.7.3 Talkiatry Telepsychiatry Products, Services and Solutions
    • 7.7.4 Talkiatry Telepsychiatry Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Talkiatry Recent Developments
  • 7.8 Talkspace
    • 7.8.1 Talkspace Profile
    • 7.8.2 Talkspace Main Business
    • 7.8.3 Talkspace Telepsychiatry Products, Services and Solutions
    • 7.8.4 Talkspace Telepsychiatry Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Talkspace Recent Developments
  • 7.9 Arcadian Telepsychiatry
    • 7.9.1 Arcadian Telepsychiatry Profile
    • 7.9.2 Arcadian Telepsychiatry Main Business
    • 7.9.3 Arcadian Telepsychiatry Telepsychiatry Products, Services and Solutions
    • 7.9.4 Arcadian Telepsychiatry Telepsychiatry Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Arcadian Telepsychiatry Recent Developments
  • 7.10 MDLIVE Behavioral Health
    • 7.10.1 MDLIVE Behavioral Health Profile
    • 7.10.2 MDLIVE Behavioral Health Main Business
    • 7.10.3 MDLIVE Behavioral Health Telepsychiatry Products, Services and Solutions
    • 7.10.4 MDLIVE Behavioral Health Telepsychiatry Revenue (US$ Million) & (2020-2025)
    • 7.10.5 MDLIVE Behavioral Health Recent Developments
  • 7.11 Thriveworks
    • 7.11.1 Thriveworks Profile
    • 7.11.2 Thriveworks Main Business
    • 7.11.3 Thriveworks Telepsychiatry Products, Services and Solutions
    • 7.11.4 Thriveworks Telepsychiatry Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Thriveworks Recent Developments
  • 7.12 Lyra Health
    • 7.12.1 Lyra Health Profile
    • 7.12.2 Lyra Health Main Business
    • 7.12.3 Lyra Health Telepsychiatry Products, Services and Solutions
    • 7.12.4 Lyra Health Telepsychiatry Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Lyra Health Recent Developments
  • 7.13 Psychiatric Alternatives
    • 7.13.1 Psychiatric Alternatives Profile
    • 7.13.2 Psychiatric Alternatives Main Business
    • 7.13.3 Psychiatric Alternatives Telepsychiatry Products, Services and Solutions
    • 7.13.4 Psychiatric Alternatives Telepsychiatry Revenue (US$ Million) & (2020-2025)
    • 7.13.5 Psychiatric Alternatives Recent Developments
  • 7.14 MyndYou
    • 7.14.1 MyndYou Profile
    • 7.14.2 MyndYou Main Business
    • 7.14.3 MyndYou Telepsychiatry Products, Services and Solutions
    • 7.14.4 MyndYou Telepsychiatry Revenue (US$ Million) & (2020-2025)
    • 7.14.5 MyndYou Recent Developments
  • 7.15 PlushCare
    • 7.15.1 PlushCare Profile
    • 7.15.2 PlushCare Main Business
    • 7.15.3 PlushCare Telepsychiatry Products, Services and Solutions
    • 7.15.4 PlushCare Telepsychiatry Revenue (US$ Million) & (2020-2025)
    • 7.15.5 PlushCare Recent Developments

8 Industry Chain Analysis

  • 8.1 Telepsychiatry Industrial Chain
  • 8.2 Telepsychiatry Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Telepsychiatry Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Telepsychiatry Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Telepsychiatry Market Trends
  • Table 2. Telepsychiatry Market Drivers & Opportunity
  • Table 3. Telepsychiatry Market Challenges
  • Table 4. Telepsychiatry Market Restraints
  • Table 5. Global Telepsychiatry Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Telepsychiatry Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Telepsychiatry Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Telepsychiatry Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Telepsychiatry
  • Table 10. Global Telepsychiatry Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Telepsychiatry as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Telepsychiatry Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Telepsychiatry Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Telepsychiatry Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Telepsychiatry Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Telepsychiatry Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Telepsychiatry Sales Value by End User: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Telepsychiatry Sales Value by End User (2020-2025) & (US$ Million)
  • Table 20. Global Telepsychiatry Sales Value by End User (2026-2031) & (US$ Million)
  • Table 21. Global Telepsychiatry Sales Market Share in Value by End User (2020-2025)
  • Table 22. Global Telepsychiatry Sales Market Share in Value by End User (2026-2031)
  • Table 23. Global Telepsychiatry Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Telepsychiatry Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Telepsychiatry Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Telepsychiatry Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Telepsychiatry Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Telepsychiatry Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Telepsychiatry Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Telepsychiatry Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Teladoc Health Basic Information List
  • Table 32. Teladoc Health Description and Business Overview
  • Table 33. Teladoc Health Telepsychiatry Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Telepsychiatry Business of Teladoc Health (2020-2025)
  • Table 35. Teladoc Health Recent Developments
  • Table 36. American Telepsychiatrists Basic Information List
  • Table 37. American Telepsychiatrists Description and Business Overview
  • Table 38. American Telepsychiatrists Telepsychiatry Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Telepsychiatry Business of American Telepsychiatrists (2020-2025)
  • Table 40. American Telepsychiatrists Recent Developments
  • Table 41. American Well Basic Information List
  • Table 42. American Well Description and Business Overview
  • Table 43. American Well Telepsychiatry Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Telepsychiatry Business of American Well (2020-2025)
  • Table 45. American Well Recent Developments
  • Table 46. Doxy.me Basic Information List
  • Table 47. Doxy.me Description and Business Overview
  • Table 48. Doxy.me Telepsychiatry Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Telepsychiatry Business of Doxy.me (2020-2025)
  • Table 50. Doxy.me Recent Developments
  • Table 51. Advanced Telemed Services Basic Information List
  • Table 52. Advanced Telemed Services Description and Business Overview
  • Table 53. Advanced Telemed Services Telepsychiatry Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Telepsychiatry Business of Advanced Telemed Services (2020-2025)
  • Table 55. Advanced Telemed Services Recent Developments
  • Table 56. Cerebral Basic Information List
  • Table 57. Cerebral Description and Business Overview
  • Table 58. Cerebral Telepsychiatry Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Telepsychiatry Business of Cerebral (2020-2025)
  • Table 60. Cerebral Recent Developments
  • Table 61. Talkiatry Basic Information List
  • Table 62. Talkiatry Description and Business Overview
  • Table 63. Talkiatry Telepsychiatry Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Telepsychiatry Business of Talkiatry (2020-2025)
  • Table 65. Talkiatry Recent Developments
  • Table 66. Talkspace Basic Information List
  • Table 67. Talkspace Description and Business Overview
  • Table 68. Talkspace Telepsychiatry Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Telepsychiatry Business of Talkspace (2020-2025)
  • Table 70. Talkspace Recent Developments
  • Table 71. Arcadian Telepsychiatry Basic Information List
  • Table 72. Arcadian Telepsychiatry Description and Business Overview
  • Table 73. Arcadian Telepsychiatry Telepsychiatry Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Telepsychiatry Business of Arcadian Telepsychiatry (2020-2025)
  • Table 75. Arcadian Telepsychiatry Recent Developments
  • Table 76. MDLIVE Behavioral Health Basic Information List
  • Table 77. MDLIVE Behavioral Health Description and Business Overview
  • Table 78. MDLIVE Behavioral Health Telepsychiatry Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Telepsychiatry Business of MDLIVE Behavioral Health (2020-2025)
  • Table 80. MDLIVE Behavioral Health Recent Developments
  • Table 81. Thriveworks Basic Information List
  • Table 82. Thriveworks Description and Business Overview
  • Table 83. Thriveworks Telepsychiatry Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Telepsychiatry Business of Thriveworks (2020-2025)
  • Table 85. Thriveworks Recent Developments
  • Table 86. Lyra Health Basic Information List
  • Table 87. Lyra Health Description and Business Overview
  • Table 88. Lyra Health Telepsychiatry Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Telepsychiatry Business of Lyra Health (2020-2025)
  • Table 90. Lyra Health Recent Developments
  • Table 91. Psychiatric Alternatives Basic Information List
  • Table 92. Psychiatric Alternatives Description and Business Overview
  • Table 93. Psychiatric Alternatives Telepsychiatry Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in Telepsychiatry Business of Psychiatric Alternatives (2020-2025)
  • Table 95. Psychiatric Alternatives Recent Developments
  • Table 96. MyndYou Basic Information List
  • Table 97. MyndYou Description and Business Overview
  • Table 98. MyndYou Telepsychiatry Products, Services and Solutions
  • Table 99. Revenue (US$ Million) in Telepsychiatry Business of MyndYou (2020-2025)
  • Table 100. MyndYou Recent Developments
  • Table 101. PlushCare Basic Information List
  • Table 102. PlushCare Description and Business Overview
  • Table 103. PlushCare Telepsychiatry Products, Services and Solutions
  • Table 104. Revenue (US$ Million) in Telepsychiatry Business of PlushCare (2020-2025)
  • Table 105. PlushCare Recent Developments
  • Table 106. Key Raw Materials Lists
  • Table 107. Raw Materials Key Suppliers Lists
  • Table 108. Telepsychiatry Downstream Customers
  • Table 109. Telepsychiatry Distributors List
  • Table 110. Research Programs/Design for This Report
  • Table 111. Key Data Information from Secondary Sources
  • Table 112. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Telepsychiatry Product Picture
  • Figure 2. Global Telepsychiatry Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Telepsychiatry Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Telepsychiatry Report Years Considered
  • Figure 5. Global Telepsychiatry Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Telepsychiatry Revenue in 2024
  • Figure 7. Telepsychiatry Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Routine Telepsychiatry Picture
  • Figure 9. Forensic Telepsychiatry Picture
  • Figure 10. Crisis Telepsychiatry Picture
  • Figure 11. In-Home Telepsychiatry Picture
  • Figure 12. Global Telepsychiatry Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 13. Global Telepsychiatry Sales Value Market Share by Type, 2024 & 2031
  • Figure 14. Product Picture of Adults
  • Figure 15. Product Picture of Teenagers
  • Figure 16. Product Picture of Geriatric Populations
  • Figure 17. Global Telepsychiatry Sales Value by End User (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 18. Global Telepsychiatry Sales Value Market Share by End User, 2024 & 2031
  • Figure 19. North America Telepsychiatry Sales Value (2020-2031) & (US$ Million)
  • Figure 20. North America Telepsychiatry Sales Value by Country (%), 2024 VS 2031
  • Figure 21. Europe Telepsychiatry Sales Value, (2020-2031) & (US$ Million)
  • Figure 22. Europe Telepsychiatry Sales Value by Country (%), 2024 VS 2031
  • Figure 23. Asia Pacific Telepsychiatry Sales Value, (2020-2031) & (US$ Million)
  • Figure 24. Asia Pacific Telepsychiatry Sales Value by Region (%), 2024 VS 2031
  • Figure 25. South America Telepsychiatry Sales Value, (2020-2031) & (US$ Million)
  • Figure 26. South America Telepsychiatry Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Middle East & Africa Telepsychiatry Sales Value, (2020-2031) & (US$ Million)
  • Figure 28. Middle East & Africa Telepsychiatry Sales Value by Country (%), 2024 VS 2031
  • Figure 29. Key Countries/Regions Telepsychiatry Sales Value (%), (2020-2031)
  • Figure 30. United States Telepsychiatry Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. United States Telepsychiatry Sales Value by Type (%), 2024 VS 2031
  • Figure 32. United States Telepsychiatry Sales Value by End User (%), 2024 VS 2031
  • Figure 33. Europe Telepsychiatry Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. Europe Telepsychiatry Sales Value by Type (%), 2024 VS 2031
  • Figure 35. Europe Telepsychiatry Sales Value by End User (%), 2024 VS 2031
  • Figure 36. China Telepsychiatry Sales Value, (2020-2031) & (US$ Million)
  • Figure 37. China Telepsychiatry Sales Value by Type (%), 2024 VS 2031
  • Figure 38. China Telepsychiatry Sales Value by End User (%), 2024 VS 2031
  • Figure 39. Japan Telepsychiatry Sales Value, (2020-2031) & (US$ Million)
  • Figure 40. Japan Telepsychiatry Sales Value by Type (%), 2024 VS 2031
  • Figure 41. Japan Telepsychiatry Sales Value by End User (%), 2024 VS 2031
  • Figure 42. South Korea Telepsychiatry Sales Value, (2020-2031) & (US$ Million)
  • Figure 43. South Korea Telepsychiatry Sales Value by Type (%), 2024 VS 2031
  • Figure 44. South Korea Telepsychiatry Sales Value by End User (%), 2024 VS 2031
  • Figure 45. Southeast Asia Telepsychiatry Sales Value, (2020-2031) & (US$ Million)
  • Figure 46. Southeast Asia Telepsychiatry Sales Value by Type (%), 2024 VS 2031
  • Figure 47. Southeast Asia Telepsychiatry Sales Value by End User (%), 2024 VS 2031
  • Figure 48. India Telepsychiatry Sales Value, (2020-2031) & (US$ Million)
  • Figure 49. India Telepsychiatry Sales Value by Type (%), 2024 VS 2031
  • Figure 50. India Telepsychiatry Sales Value by End User (%), 2024 VS 2031
  • Figure 51. Telepsychiatry Industrial Chain
  • Figure 52. Telepsychiatry Manufacturing Cost Structure
  • Figure 53. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 54. Bottom-up and Top-down Approaches for This Report
  • Figure 55. Data Triangulation
  • Figure 56. Key Executives Interviewed